In this illustrated poster, downstream monoclonal antibody design space is modeled. Traditional batch downstream processes are modeled and compared to a continuous downstream model. Sources of potential savings are identified and costs are compared for these processes across a range of fed-batch bioreactor volumes, titers and yearly batch numbers.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.